LYCOS RETRIEVER 
Serzone: Bristol-Myers Squibb
built 279 days ago
In 2001, worldwide sales of Serzone were $409 million. On May 19th, 2004 Bristol-Myers Squibb announced that due to declining sales, Serzone will no longer be sold in the U.S. after June 14th, 2004. Note that this action does not affect sales of generic versions of Serzone (nefazodone).
Source:
Serzone, (nefazodone hydrochloride) (website) Bristol-Myers Squibb Company (website), is a medicine used to treat depression. SERZONE is thought to treat depression by correcting an imbalance in the amounts of certain natural chemicals, such as serotonin and norepinephrine, which are in your brain.
Source:
Serzone® (nefazodone HCl) is used to treat depression. It is administered in tablet form, in dosages of 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg. Serzone is manufactured by Bristol-Myers Squibb Co. Worldwide sales of Serzone were $409 million in 2001.
Source:
Bristol-Myers Squibb Company manufactures the antidepressant Serzone. The drug is ... known as nefazodone hydrochloride and has been marketed and sold in the United States since December 1994. It has been linked to dangerous side effects such as liver toxicity, liver failure, severe hepatic injuries and death. Recently, Bristol-Myers announced that it will withdraw Serzone from the United States beginning on June, 14 2004. The announced withdrawal from the market is coming on the wake of increased reports of liver toxicity of the drug and product withdrawals in foreign countries.
Source:
Serzone is the name brand of a tablet form of nefazodone, a prescription medication used to reduce the psychological and physical symptoms of depression, anxiety, and related disorders. Available in dosages of 50 mg, 100 mg, 150mg, 200mg, and 250mg, Serzone is manufactured by Bristol-Myers Squibb Company.
Source:
Bristol-Myers Squibb announced today that it is pulling its antidepressant Serzone (nefazodone) from the U.S. market. The controversial antidepressant has already been banned from sale in many countries because of links to cases of liver failure and injury, and at least 20 deaths. The company reportedly notified wholesalers that distribution of Serzone would end June 14. They insist that the medication is being pulled because of declining sales, rather than concerns about its safety.
Source:
MORE ABOUT
Bristol-Myers Squibb